Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Kevin Baird

Showing results (1-10 of 192) with videos related to

Pageof 20
Sort By:
Travel Medicine and Infectious Disease|June 17, 2019
"Lively" invasive Plasmodium vivax causes severe and complicated malariaJ Kevin Baird
Journal of Vector Borne Diseases|May 10, 2019
Essential guidance on malaria elimination in its historyJ Kevin Baird
Lancet (London, England)|March 2, 2017
Telling the human story of Asia's invisible malaria burdenJ Kevin Baird
Journal of Travel Medicine|November 1, 2018
Tafenoquine for travelers' malaria: evidence, rationale and recommendationsJ Kevin Baird
Travel Medicine and Infectious Disease|March 5, 2013
Suppressive chemoprophylaxis invites avoidable risk of serious illness caused by Plasmodium vivax malariaJ Kevin Baird
BMC Public Health|June 23, 2017
Malaria control by commodities without practical malariologyJ Kevin Baird
Antimicrobial Agents and Chemotherapy|March 9, 2011
Resistance to chloroquine unhinges vivax malaria therapeuticsJ Kevin Baird
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 5, 2011
Radical cure: the case for anti-relapse therapy against all malariasJ Kevin Baird
Current Infectious Disease Reports|March 15, 2012
Elimination therapy for the endemic malariasJ Kevin Baird
Antimicrobial Agents and Chemotherapy|October 27, 2004
Chloroquine resistance in Plasmodium vivaxJ Kevin Baird
Pageof 20

Showing results (1-10 of 192) with videos related to

Sort By:
Pageof 20
Travel Medicine and Infectious Disease|June 17, 2019
"Lively" invasive Plasmodium vivax causes severe and complicated malariaJ Kevin Baird
Journal of Vector Borne Diseases|May 10, 2019
Essential guidance on malaria elimination in its historyJ Kevin Baird
Lancet (London, England)|March 2, 2017
Telling the human story of Asia's invisible malaria burdenJ Kevin Baird
Journal of Travel Medicine|November 1, 2018
Tafenoquine for travelers' malaria: evidence, rationale and recommendationsJ Kevin Baird
Travel Medicine and Infectious Disease|March 5, 2013
Suppressive chemoprophylaxis invites avoidable risk of serious illness caused by Plasmodium vivax malariaJ Kevin Baird
BMC Public Health|June 23, 2017
Malaria control by commodities without practical malariologyJ Kevin Baird
Antimicrobial Agents and Chemotherapy|March 9, 2011
Resistance to chloroquine unhinges vivax malaria therapeuticsJ Kevin Baird
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 5, 2011
Radical cure: the case for anti-relapse therapy against all malariasJ Kevin Baird
Current Infectious Disease Reports|March 15, 2012
Elimination therapy for the endemic malariasJ Kevin Baird
Antimicrobial Agents and Chemotherapy|October 27, 2004
Chloroquine resistance in Plasmodium vivaxJ Kevin Baird
Pageof 20